DF Dent & Co’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
DF Dent & Co's LGND Position: Q3 2026 in Review
DF Dent & Co opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 48,485 shares worth $15.1M. The stake represents 0.31% of the portfolio and ranks #84 among its holdings.
433 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- DF Dent & Co held 48,485 shares of Ligand Pharmaceuticals worth $15.1M as of Q3 2026.
- Ligand Pharmaceuticals was a new DF Dent & Co position in Q3 2026.
- Ligand Pharmaceuticals made up 0.31% of DF Dent & Co's portfolio in Q3 2026, its #84 holding.
- 433 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on DF Dent & Co's 13F filing for Q3 2026, filed 16 Nov 2026.